Sera is a women’s health diagnostics company dedicated to improving the lives of women and babies through precision pregnancy care. Sera provides pivotal information during pregnancy to physicians, designed to help improve the health of their patients, and to reduce the costs of healthcare delivery. Sera is the first to launch a simple blood test (PreTRM®) that biologically identifies, and reports, to a physician the individualized risk of spontaneous premature delivery in a pregnancy, enabling earlier proactive interventions in women with higher risk. Early identification, and appropriate evidence-based treatment, help to prolong gestational age and improve newborn health.
Contact name: Shawn McGinnis, National Director, Employer Markets
Note: Neither the providers nor their products or services have been reviewed, tested or screened by the International Foundation. You should exercise caution and due diligence to ascertain the appropriateness, quality and value of the products and services for their intended purpose and the financial stability of the affected provider. The International Foundation does not endorse, sponsor or promote any of the products or services offered by the providers in the Service Provider Directory.